Broach Lifecare Hospital Limited IPO
Broach Lifecare Hospital Limited specializes in providing dedicated, round-the-clock services for heart patients, encompassing both non-invasive and interventional cardiology. The services include:
i. Non-Invasive Cardiology: 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, and Dobutamine Stress Echocardiography.
ii. Interventional Cardiology (since June/July 2023): Coronary angiography, stenting, percutaneous coronary intervention (PCI), primary PCI for acute myocardial infarction, balloon mitral valvuloplasty, permanent pacemaker implantation, cardiac resynchronization procedures, implantable cardioverter-defibrillator (AICD) implantation, and procedures for congenital heart ailments.
iii. Diagnostic and Therapeutic Services: Endovascular revascularization, deep vein thrombosis treatment, and peripheral angioplasty.
Facilities
The main hospital in Bharuch is an ultra-luxury 25-bed facility equipped with state-of-the-art diagnostic and treatment devices, including high-end coronary care equipment. The Satellite Hospital in Ankleshwar is a 15-bed nursing home that functions as a referral center, providing essential day-to-day non-surgical treatments.
Both hospitals are certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and possess certifications for PACS System and Fire Safety from local regulatory bodies. Additionally, the company is a member of Globe Bio Care for biomedical waste disposal.
Strategic Advantages
Broach Lifecare Hospital Limited is strategically positioned near the industrial belt of Bharuch and Ankleshwar, facilitating partnerships with public sector undertakings and private companies for employee healthcare services and routine medical check-ups. The company also collaborates with insurance companies to process admissible claims, enhancing patient convenience.
By engaging prominent medical specialists as consultants and adhering to treatment protocols that meet acceptable standards, Broach Lifecare Hospital Limited strives to deliver top-tier medical services at competitive prices, reinforcing its reputation for quality care in the healthcare industry.
Objects of the Broach Lifecare Hospital Limited IPO:
Broach Lifecare Hospital Limited IPO Details:
Open Date: | Aug 13 2024 |
Close Date: | Aug 16 2024 |
Total Shares: | 1,608,000 |
Face Value: | ₹ 10 Per Equity Share |
Issue Size: | 4.02 Cr. |
Lot Size: | 6000 Shares |
Issue Price: | ₹ 25 Per Equity Share |
Listing At: | BSE SME |
Listing Date: | Aug 21 2024 |
Promoters And Management:
Financials of Broach Lifecare Hospital Limited IPO:
Particulars ( In Lakhs ) |
2024 |
Revenue from Operations | 261 |
Other Income | 0 |
Total Revenue | 261 |
Cost of services | 25 |
Consumed - Medicines and consumables | 44 |
Employees Benefit Expenses | 51 |
Other Expenses | 39 |
EBITDA | 103 |
OPM (%) | 39.37% |
Depreciation & Amortisation | 9 |
EBIT | 93 |
Finance Cost | 0.1 |
PBT | 93 |
Tax | 24 |
PAT | 70 |
NPM (%) | 26.77% |
No.of Shares | 60.7 |
EPS | 1.15 |
Comparison With Peers:
Name of the Company | Revenue (In Crore) | PAT (In Crore) | EPS ( in Rs) | P/E | CMP | Mcap (In Crore) |
Broach Lifecare Hospital Limited | 3 | 1 | 1.15 | 21.8 | 25 | 15 |
Family Care Hospitals Limited | 40 | 13 | 2.32 | 3.3 | 7.59 | 41 |
KMC Speciality Hospitals (India) Limited | 177 | 30 | 1.86 | 45.7 | 85.1 | 1,387 |
Global Longlife Hospital and Research Limited | 14 | -2 | -2.09 | N/A | 30.9 | 32 |
Recommendation on Broach Lifecare Hospital Limited IPO:
To be updated shortly.
Lead Manager of Broach Lifecare Hospital Limited IPO:
Registrar of Broach Lifecare Hospital Limited IPO:
Company Address:
Discussion on Broach Lifecare Hospital Limited IPO:
Leave a Reply
You must be logged in to post a comment.